Automated SMS-Based Appointment Validation Tool

Early Phase 1

• Conditions: Adult-onset Diabetes; Diabetes Mellitus Type 2

• Registration Number: NCT01671189
• Lead Sponsor: Medic Mobile

Brief Summary

Medic Mobile conceptualized and proposed the creation of an SMS-based appointment validation tool to automate appointment confirmation and rescheduling. Working in parallel with the San Mateo Medical Center (SMMC) electronic medical records (EMR) system, the software tool will automate reminders that request text responses from patients to either confirm or request to reschedule their upcoming appointments. While simple in concept, this tool aims to free up scarce clinical resources which are currently allocated to daily patient phone call reminders. With funding from a Bay Area foundation, the investigators will develop and pilot this open-source software tool in a 12-month randomized-controlled trial, slated to begin in October 2012. The endpoints of the study will aim to demonstrate improvements in both appointment adherence and glycemic control.

Detailed Description

Not available

Study Timeline

• Status Verified: 2012-08
• Study First Submitted: 2012-08-20
• Study First Submitted QC: 2012-08-22
• Last Update Submitted: 2012-08-22
• Study First Posted: 2012-08-23
• Last Update Posted: 2012-08-23
• Study Start: 2012-10
• Primary Completion: 2013-10
• Study Completion: 2013-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

• Belong to Willow Clinic or Fair Oaks Clinic under the San Mateo Medical Center
• Have a diagnosis of type 2 diabetes as indicated by ICD-9 code of 249.xx or 250.xx
• Have a most recent hemoglobin A1c (HbA1c) level greater than 7%
• Are at least 18 years of age
• Have access to cell phone
• Are literate or live with a friend/family member who is literate and willing to handle associated text messages

Exclusion Criteria

• Have a terminal illness and prognosis of less than one year
• Are unable to demonstrate the ability to reply to an SMS and lack an appropriate proxy
• Are pregnant or expect to be pregnant in the next 6-9 months

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Glycemic Control (hemoglobin A1c)	6-9 months post-enrollment	The hemoglobin A1c (HbA1c) levels of study participants will be measured at the time of enrollment and at the end of the 6-9 month follow-up period.

Secondary Outcome Measures

Name	Time	Method
Appointment Adherence Rate	6-9 month post-enrollment	Appointments scheduled during the 6-9 month follow-up period will be systematically tracked and monitored. The proportion of fulfilled appointments will be compared between the intervention and control arms.

Trial Locations

Locations (1)

San Mateo Medical Center; 🇺🇸 San Mateo, California, United States